2018 Value of Medicines - Applications Now Closed
Every year since 2011, Medicines New Zealand has awarded outstanding researchers for undertaking innovative research into the use of medicines or vaccines in New Zealand. The annual Value of Medicines Award winner receives a $20,000 grant to invest in a new or ongoing research project.
2018 is the first year we have widened our selection criteria beyond research into existing medicines and vaccines, to also reward and stimulate fundamental, translational and clinical research into promising novel treatments, and studies investigating new ways of using existing medicines and vaccines to treat more medical conditions.
Applications closed midnight Sunday 30 September 2018.
2017 Value of Medicines Award Winner - Lisa Stamp
Louisa Wall MP, Jill Drake, Lisa Stamp and Dr Graeme Jarvis
Professor Lisa Stamp is the Director of Arthritis Research at the University of Otago, Christchurch. She received the award for her and her colleague's research into Allopurinol, the most commonly used medicine to manage gout in New Zealand.
Her research was the first randomized controlled trial in the world to show that increasing the dose of allopurinol over time, until a patient’s uric acid levels respond is more effective than standard dosing, without increasing side effects. This has influenced international treatment guidelines and will improve the management of gout, a painful disease affecting many New Zealanders.